Product Description
| Brand | Abbott |
| Sample Type | Nasopharyngeal |
| Pack Size | 24T |
| CAT No | 427000 |
The ID NOW Influenza A & B 2 assay delivers molecular flu results in 13 minutes or less on our unique ID NOW platform; making it significantly faster than other molecular methods and more accurate than conventional rapid tests. Rapid diagnostic tests with increased sensitivity are essential for the reliable detection of influenza A and B and enable immediate, effective treatment decisions.
Rapid and Accurate Influenza DetectionThe ID NOW INFLUENZA A & B 2 analyzer enables rapid and highly accurate screening of Influenza A & B, facilitating timely clinical decision-making. Its molecular isothermal amplification technology ensures precise results, limiting the risk of false negatives or positives. Fast turnaround times reduce patient waiting periods and support efficient infection control in point-of-care settings.
Designed for Versatility and PortabilityCompact and lightweight at just 2.7 kg, the device suits a range of clinical environments. The analyzer operates automatically once a nasopharyngeal swab sample is loaded manually, making it ideal for busy clinics and emergency settings. With a low-noise profile, LED indicator lights, and USB connectivity, it seamlessly integrates into modern healthcare workflows.
FAQ's of Abbott ID NOW INFLUENZA A & B 2:
Q: How does the Abbott ID NOW INFLUENZA A & B 2 detect influenza viruses?
A: It uses isothermal nucleic acid amplification (NAT) technology to rapidly detect and identify Influenza A and B viruses with high specificity and sensitivity from a nasopharyngeal swab sample.
Q: What is the process for running a test with this analyzer?
A: First, collect a nasopharyngeal swab sample and manually load it into the device. The instrument then automatically carries out the analysis, providing digital results in under 15 minutes, with minimal hands-on intervention required.
Q: When should this analyzer be used?
A: The device is suitable for clinical diagnostics at the point of care, particularly when rapid results are crucial, such as during flu season or possible outbreak scenarios in healthcare facilities.
Q: Where can the Abbott ID NOW INFLUENZA A & B 2 be utilized?
A: This analyzer is designed for use in hospitals, clinics, and laboratories. Its portability and compact size make it convenient for near-patient testing in various healthcare settings.
Q: What are the storage and maintenance instructions for the device?
A: Store the instrument in a dry location at room temperature. Clean it with easy wipe methods and ensure annual calibration for optimal performance and accuracy.
Q: What are the benefits of using this analyzer?
A: It offers rapid, reliable influenza diagnosis with high accuracy, reducing waiting times and improving clinical workflow. The compact design and automatic operation make it practical for immediate, on-site testing.
Q: How is data output managed on the device?
A: Results are displayed digitally on the device and can be printed or exported via the USB port for documentation or electronic medical record integration.